The role of nitric oxide in cardiac depression induced by interleukin‐1β and tumour necrosis factor‐α

British Journal of Pharmacology

Volumn 114, Issue 1, 1995, Pages 27-34

  Schulz, Richard ^a   Panas, Donna L ^a   Catena, Robert ^a   Moncada, Salvador ^b   Olley, Peter M ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

cycloheximide; interleukin 1 ; myocardial contraction; NG nitro l arginine methyl ester (l NAME); Nitric oxide; nitric oxide synthase; shock; tumour necrosis factor ; working heart

Indexed keywords

CYCLOHEXIMIDE; CYTOKINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HEART WORK; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

AMINO ACID OXIDOREDUCTASES; ANIMAL; ARGININE; CORONARY CIRCULATION; INTERLEUKIN-1; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0028963283     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb14901.x     Document Type: Article

References (53)

1. Myocardial function in sepsis and endotoxin shock
2. Expression of tumor necrosis factor in human acute cardiac rejection
3. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage‐conditioned medium
4. Characterization of a cytokine‐inducible isoform of nitric oxide synthase in cardiac microvascular endothelial cells
5. Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high‐dose interleukin‐2 bolus treatment
6. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
7. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
8. Nitric oxide attenuates cardiac myocyte contraction
9. Induction of nitric oxide synathase by cytokines in vascular smooth muscle cells
10. G‐nitro L‐arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists
11. Myocardial dysfunction in sepsis
12. Lysoplasmenylethanolamine accumulation in ischemic/reperfused isolated fatty acid‐perfused hearts
13. Nitric oxide synthase activities in human myocardium
14. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma
15. The proinflammatory cytokines interleukin‐1 and tumor necrosis factor and treatment of the septic shock syndrome
16. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L‐arginine‐dependent inhibition of mitochondrial iron‐sulfur enzymes in the macrophage effector cells
17. Interleukin‐1β modulates myocardial contraction via dexamethasone sensitive production of nitric oxide
18. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
19. Interferon‐γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells
20. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L‐arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron
21. Evidence for cytokine‐inducible nitric oxide synthesis from L‐arginine in patients receiving interleukin‐2 therapy
22. Interleukin‐1‐induced myocardial depression in an isolated beating heart preparation
23. Circulatory effects of hydrocortisone and protection against endotoxin shock in cats
24. Induction of endogenous cytokine‐mRNA in circulating peripheral blood mononuclear cells by IL‐2 administration to cancer patients
25. Control of coronary vascular tone by nitric oxide
26. G‐methyl‐L‐arginine inhibits tumor necrosis factor‐induced hypotension: implications for the involvement of nitric oxide
27. EPR detection of heme and nonheme iron‐containing protein nitrosylation by nitric oxide during rejection of rat heart allograft
28. Cardiac allograft rejection induces myocardial nitric oxide synthase
29. Nitric oxide: physiology, pathophysiology and pharmacology
30. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
31. Effect of pressure development on membrane transport of glucose in isolated rat heart
32. Myocardial toxic effects during recombinant interleukin‐2 therapy
33. Interleukin‐2 administration causes reverible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock
34. Development of myocardial dysfunction in endotoxin shock
35. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
36. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock
37. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
38. 2+‐independent nitric oxide synthase in the myocardium
39. Nitric oxide synthase in cultured endocardial cells of the pig
40. Role of NO in vascular smooth muscle and cardiac muscle function
41. Modulation of myocardial contraction by endocardial and coronary vascular endothelium
42. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase
43. Factors released from endocardium of the ferret and pig modulate myocardial contraction
44. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart
45. Effects of interleukin 2 on cardiac function in the isolated rat heart
46. Effects of E. coli endotoxemia on ventricular performance
47. The cardiovascular response to normal humans to the administration of endotoxin
48. Left ventricular contractility and diastolic properties in anesthetized dogs after severe burns
49. Utilization of energy providing substrates in the isolated working rat heart
50. Tumor necrosis factor, other cytokines and disease
51. Protective and pathological roles of nitric oxide in endotoxin shock
52. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half‐life
53. The role of cachetin/TNF and other cytokines in sepsis